IMM 1.69% 30.0¢ immutep limited

one poster's well researched opinion, page-25

  1. 169 Posts.
    So much attention was focussed on the FDA by a congressional hearing regarding the rejection of provenge. Remember the first FDA panel gave provenge the thumbs up.
    I think some of those people in the FDA has moved on.
    Since the approval of provenge, I believed the FDA has written new guidelines on cancer treatment using immunology, thus paving an easier way for CVAC.
    I think people should have a choice of having cvac first before chemo because chemo has side effects.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.